Survey of Immunization Practices in Patients with Inflammatory Bowel Disease among Pediatric Gastroenterologists

Journal of Pediatric Gastroenterology and Nutrition

Volumn 61, Issue 1, 2015, Pages 47-51

  Lester, Rachael ^a   Lu, Ying ^b   Tung, Jeanne ^c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Crohn disease; immunization; inflammatory bowel disease; pediatrics; vaccine

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; WART VIRUS VACCINE; VACCINE;

CONFERENCE PAPER; FEMALE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; HEALTH BELIEF; HEALTH CARE ACCESS; HUMAN; IMMUNIZATION; INFLAMMATORY BOWEL DISEASE; MALE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; PARENTAL ATTITUDE; PEDIATRIC GASTROENTEROLOGIST; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMINDER SYSTEM; TRANSITION TO ADULT CARE; VACCINATION; ADOLESCENT; CHICKENPOX; CHILD; CLINICAL PRACTICE; COMPLICATION; GASTROENTEROLOGY; HEALTH PERSONNEL ATTITUDE; HEPATITIS B; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA, HUMAN; PEDIATRICS; QUESTIONNAIRE; VIRUS DISEASES;

ADOLESCENT; ATTITUDE OF HEALTH PERSONNEL; CHICKENPOX; CHILD; FEMALE; GASTROENTEROLOGY; HEPATITIS B; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; INFLUENZA, HUMAN; MALE; PEDIATRICS; PRACTICE PATTERNS, PHYSICIANS'; REMINDER SYSTEMS; SURVEYS AND QUESTIONNAIRES; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 84937739106     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000730     Document Type: Conference Paper

References (15)

1. Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1417-23.
2. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:677-92.
3. Wasan SK, Baker SE, Skolnik PR, et al. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010; 105:1231-8.
4. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis 2011;17:2536-40.
5. Wasan SK, Calderwood AH, Long MD, et al. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis 2014;20:246-50.
6. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58:e44-100.
7. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pediatric Gastroenterology Workforce Survey, 2003-2004. J Pediatr Gastroenterol Nutr 2005; 40: 397-405.
8. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-6.
9. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastro-enterol 2009;104:444-53.
10. Debruyn JC, Hilsden R, Fonseca K, et al. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:25-33.
11. Gisbert JP, Villagrasa JR, Rodŕiguez-Nogueiras A, et al. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastro-enterol 2012;107:1460-6.
12. Gisbert JP, Villagrasa JR, Rodŕiguez-Nogueiras A, et al. Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:554-8.
13. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010;105:148-54.
14. Lee CK, Kim HS, Ye BD, et al. Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine. J Crohns Colitis 2014;8:384-91. http://dx.doi.org/10.1016/j.crohns. 2013.09.022.
15. Fiorino G, Peyrin-Biroulet L, Naccarato P, et al. Effects of immuno-suppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis 2012; 18:1042-7.